Sage Therapeutics, Inc. Operating Leases, Rent Expense, Net
Sage Therapeutics, Inc. reported Operating Leases, Rent Expense, Net of $10.20 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseNet · last filed 2021-02-24
- Sage Therapeutics, Inc. operating leases, rent expense, net for fiscal 2019 was $10.20M, a 56.92% increase from fiscal 2018.
- Sage Therapeutics, Inc. operating leases, rent expense, net for fiscal 2018 was $6.50M, a 75.68% increase from fiscal 2017.
- Sage Therapeutics, Inc. operating leases, rent expense, net for fiscal 2017 was $3.70M, a 85.00% increase from fiscal 2016.
- Sage Therapeutics, Inc. operating leases, rent expense, net for fiscal 2016 was $2.00M, a 400.00% increase from fiscal 2015.
| Period end | Operating Leases, Rent Expense, Net 12 month | Operating Leases, Rent Expense, Net 12 month as first filed |
|---|---|---|
| 2019-12-31 | $10.20M 10-K · filed 2020-02-27 | |
| 2018-12-31 | $6.50M 10-K · filed 2021-02-24 | |
| 2017-12-31 | $3.70M 10-K · filed 2020-02-27 | |
| 2016-12-31 | $2.00M 10-K · filed 2019-02-19 | |
| 2015-12-31 | $400.00K 10-K · filed 2018-02-22 | |
| 2014-12-31 | $300.00K 10-K · filed 2017-02-24 | $302.00K 10-K · filed 2015-03-06 |
| 2013-12-31 | $300.00K 10-K · filed 2016-02-29 | $274.00K 10-K · filed 2015-03-06 |
| 2012-12-31 | $194.00K 10-K · filed 2015-03-06 |